Power Law company profile

Sorrento Therapeutics

Biotech & Life Sciences · San Diego, United States · Founded 2006 · IPO 2010 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$128M

Market cap · Apr/2026

Revenue

$63M

Latest reported FY

Global footprint

Where Sorrento Therapeutics has talent and traffic

Web traffic by country

1.4K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Patent intelligence

$128M patent portfolio · 94 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$128M

100.0% of market cap · comparable to top peer Constellation Pharmaceuticals ($116M)

94 active patent families

Where Sorrento Therapeutics innovates Antibody fragmentsNucleic acidAntiendomysial antibodiesMolecular biologyAnti antibody

Below peer median on Strategic

Quality vs same-sector peers

Sorrento Therapeutics on the five Patsnap quality dimensions

Sorrento Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Sorrento Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Sorrento Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Sorrento Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo